Abbott Laboratories (ETR:ABL)
93.40
+3.08 (3.41%)
Feb 2, 2026, 3:47 PM CET
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of €159.97 billion as of February 2, 2026. Its market cap has decreased by -14.58% in one year.
Market Cap
159.97B
Enterprise Value
164.64B
Revenue
37.75B
Ranking
n/a
PE Ratio
28.79
Stock Price
€93.40
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 159.97B, an increase of 25,041.22%. That is a compound annual growth rate of 9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 159.97B | -13.79% |
| Dec 31, 2025 | 185.55B | -2.08% |
| Dec 31, 2024 | 189.49B | 9.61% |
| Dec 29, 2023 | 172.88B | -3.48% |
| Dec 30, 2022 | 179.12B | -15.60% |
| Dec 31, 2021 | 212.23B | 38.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.59B |
| Siemens Healthineers AG | 47.05B |
| Bayer Aktiengesellschaft | 43.78B |
| Fresenius SE & Co. KGaA | 26.59B |
| Sartorius Aktiengesellschaft | 14.92B |
| Fresenius Medical Care AG | 10.52B |
| Fielmann Group AG | 3.48B |
| Carl Zeiss Meditec AG | 2.45B |